Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Exscientia plc (EXAI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
6.29-0.23 (-3.53%)
At close: 04:00PM EDT
6.15 -0.14 (-2.23%)
After hours: 07:55PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close6.52
Open6.56
Bid5.50 x 800
Ask6.95 x 800
Day's Range6.27 - 6.68
52 Week Range4.09 - 16.45
Volume141,760
Avg. Volume274,152
Market Cap772.903M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.42
Earnings DateMar 23, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for EXAI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Exscientia Plc
    Daily – Vickers Top Insider Picks for 03/09/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    14 days agoArgus Research
View more
  • Business Wire

    Exscientia to Report Full Year 2022 Financial Results on March 23, 2023

    OXFORD, England, March 16, 2023--Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 23, 2023 before the open of U.S. markets. The Company will host a conference call and webcast at 12:30 p.m. GMT / 8:30 a.m. EDT to provide a business update and review financial results.

  • Business Wire

    Exscientia to Present Data Highlighting Pipeline and Precision Medicine Platform at AACR

    OXFORD, England, March 15, 2023--Exscientia plc (Nasdaq: EXAI) today announced that four abstracts have been accepted for poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held April 14-19, 2023, at the Orange County Convention Center in Orlando, FL. These abstracts highlight the components of Exscientia's approach to precision discovery, design and personalised medicine as well as planned innovation in the clinic.

  • Business Wire

    Exscientia Announces Expansion of its Precision Oncology Pipeline

    OXFORD, England, March 14, 2023--Exscientia plc (Nasdaq: EXAI) today announced two new wholly-owned precision oncology development candidates, EXS74539 (‘539), an LSD1 inhibitor, and EXS73565 ('565), a MALT1 protease inhibitor. These compounds have been precision designed to improve the potential for patient benefit and solve complex design issues that may limit the probability of success of other compounds in development. IND-enabling studies are underway and the Company expects to provide an u

Advertisement
Advertisement